Clinical trial
Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
NCT00056004 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00056004 |
|---|---|
| Title | Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia |
| Official title | Phase II Trial Of Zileuton In Persons With Bronchial Dysplasia |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Lung Cancer |
| Intervention type | Drug |
| Interventions | zileuton |
| Enrollment | 38 |
| Start date | Jun 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Mar 1, 2009 |
| First posted | Mar 7, 2003 |
| Last update posted | Apr 29, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: